Skip to main content

Advertisement

SpringerLink
Log in

Adenoviral Oncolytic Suicide Gene Therapy for a Peritoneal Dissemination Model of Gastric Cancer in Mice

  • Translational Research and Biomarkers
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Peritoneal dissemination of gastric cancer is often refractory to systemic therapies. Although adenoviral gene therapy has been reported to be a potentially useful therapeutic modality, the adenovirus itself has a dose-limiting toxicity. A novel system was constructed using adenoviral oncolytic suicide gene therapy targeting carcinoembryonic antigen (CEA), and its therapeutic effect and the possibility to reduce the total viral dose while still preserving the antitumor effect were assessed.

Methods

Three types of adenoviruses were prepared for this novel system: (A) Ad/CEA-Cre, (B) Ad/lox-CD::UPRT for a Cre/loxP system, and (C) Ad/CEA-E1 for conditionally replicating adenovirus. The antitumor effect of the oncolytic suicide gene therapy (A + B + C) was then evaluated in vitro. Mice bearing peritoneal dissemination of human gastric cancer were treated with either this system (A + B + C) or with a tenfold viral dose of suicide gene therapy (A + B). The adverse effects in terms of hepatotoxicity were then evaluated between the two groups.

Results

The current system (A + B + C) demonstrated significantly better cytotoxic effect for CEA-producing cell lines than did suicide gene therapy (A + B) at the same viral dose in vitro. The effect of oncolytic suicide gene therapy was almost equal to that of the tenfold viral dose of suicide gene therapy in vivo. The hepatotoxicity of the two treated groups was also found to be equivalent.

Conclusion

It was possible to reduce the total adenoviral dose of oncolytic suicide gene therapy while still preserving the antitumor effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33–64.

    Article  CAS  PubMed  Google Scholar 

  2. Dupont JB, Lee JR, Burton GR, Cohn I. Adenocarcinoma of the stomach: review of 1497 cases. Cancer. 1978;41:941–7.

    Article  PubMed  Google Scholar 

  3. Yamada E, Miyaishi S, Yamauchi M, et al. The surgical treatment of cancer of the stomach. Int Surg. 1980;65:387–99.

    CAS  PubMed  Google Scholar 

  4. Bando E, Yonemura Y, Miwa K, et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg. 1999;178:256–62.

    Article  CAS  PubMed  Google Scholar 

  5. Yonemura Y, Bandou E, Kawamura T, Endou Y, Sasaki T. Quantitative prognostic indicators of peritoneal dissemination of gastric cancer. Eur J Surg Oncol. 2006;32:602–6.

    Article  CAS  PubMed  Google Scholar 

  6. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding. Oncology. 2000;58:96–107.

    Article  CAS  PubMed  Google Scholar 

  7. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg. 1998;228:347–54.

    Article  CAS  PubMed  Google Scholar 

  8. Nakajima T, Nishi M, Kajitani T. Improvement in treatment results of gastric cancer with surgery and chemotherapy: experience of 9,700 cases in the Cancer Institute Hospital, Tokyo. Semin Surg Oncol. 1991;7:365–72.

    Article  CAS  PubMed  Google Scholar 

  9. Shimada K, Ajani JA. Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of western and oriental trials. Cancer. 1999;86:1657–68.

    Article  CAS  PubMed  Google Scholar 

  10. Noh SH, Yoo CH, Chung HC, Roh JK, Shin DW, Min JS. (2001) Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer. Oncology. 60:24–30.

    Article  CAS  PubMed  Google Scholar 

  11. Fujimura T, Yonemura Y, Shibata K, et al. Subtotal peritonectomy with chemohyperthermic peritoneal perfusion for peritonitis carcinomatosa in gastrointestinal cancer. Oncol Rep. 2000;7:809–14.

    CAS  PubMed  Google Scholar 

  12. Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5:219–28.

    Article  PubMed  Google Scholar 

  13. Jeung HC, Rha SY, Jang WI, Noh SH, Chung HC. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. Br J Surg. 2002;89:460–6.

    Article  CAS  PubMed  Google Scholar 

  14. Takei Y, Saga Y, Mizukami H, Takayama T, Ohwada M, Ozawa K, et al. Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice. Mol Cancer Ther. 2008;7:704–11.

    Article  CAS  PubMed  Google Scholar 

  15. Fu X, Tao L, Zhang X. An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer. Cancer Gene Ther. 2007;14:480–7.

    Article  CAS  PubMed  Google Scholar 

  16. Yu HK, Ahn JH, Lee HJ, Lee SK, Hong SW, Yoon Y, et al. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination. J Gene Med. 2005;7:39–49.

    Article  CAS  PubMed  Google Scholar 

  17. Miura Y, Ohnami S, Aoki K, et al. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity. Cancer Lett. 2005;218:53–62.

    Article  CAS  PubMed  Google Scholar 

  18. Tanaka F, Tominaga K, Arakawa T, et al. Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity. Cancer Gene Ther. 2008;15:51–9.

    Article  CAS  PubMed  Google Scholar 

  19. Miyagi M, Aoyagi K, Kato S, Shirouzu K. The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer. Int J Clin Oncol. 2007;12:17–24.

    Article  CAS  PubMed  Google Scholar 

  20. Tsunemitsu Y, Kagawa S, Fujiwara T, et al. Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer. Gut. 2004;53:554–60.

    Article  CAS  PubMed  Google Scholar 

  21. Zhang WW. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther. 1999;6:113–38.

    Article  CAS  PubMed  Google Scholar 

  22. Lan KH, Kanai F, Omata M, et al. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma. Cancer Res. 1997;57:4279–84.

    CAS  PubMed  Google Scholar 

  23. Ueda K, Iwahashi M, Nakamori M, Nakamura M, Matsuura I, Yamaue H, et al. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the Cre/loxP system in the orthotopic gastric carcinoma model. Cancer Res. 2001;61:6158–62.

    CAS  PubMed  Google Scholar 

  24. Kijima T, Osaki T, Kishimoto T, et al. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Cancer Res. 1999;59:4906–11.

    CAS  PubMed  Google Scholar 

  25. Goto H, Osaki T, Hayashi S, et al. Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells. Int J Cancer. 2001;94:414–9.

    Article  CAS  PubMed  Google Scholar 

  26. Nishiyama T, Kawamura Y, Sakai T, et al. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res. 1985;45:1753–61.

    CAS  PubMed  Google Scholar 

  27. Chung-Faye GA, Chen MJ, Kerr DJ, et al. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase. Gene Ther. 2001;8:1547–54.

    Article  CAS  PubMed  Google Scholar 

  28. Heise CC, Williams AM, Xue S, Propst M, Kirn DH. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy. Cancer Res. 1999;59:2623–8.

    CAS  PubMed  Google Scholar 

  29. Sato Y, Tanaka K, Saito I, et al. Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector. Biochem Biophys Res Commun. 1998;244:455–62.

    Article  CAS  PubMed  Google Scholar 

  30. Reid T, Warren R, Kirn D. Intravascular adenoviral agents in cancer patients: lessons from clinical trials. Cancer Gene Ther. 2002;9:979–86.

    Article  CAS  PubMed  Google Scholar 

  31. Small EJ, Carducci MA, Wilding G, et al. A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer. Mol Ther. 2006;14:107–17.

    Article  CAS  PubMed  Google Scholar 

  32. Tanaka T, Huang J, Hamada H, et al. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin Cancer Res. 2006;12:3803–13.

    Article  CAS  PubMed  Google Scholar 

  33. Akbulut H, Zhang L, Tang Y, Deisseroth A. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther. 2003;10:388–95.

    Article  CAS  PubMed  Google Scholar 

  34. Yamamoto M, Davydova J, Wang M, Siegal GP, Krasnykh V, Vickers SM, et al. Sectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer. Gastroenterology. 2003;125:1203–18.

    Article  CAS  PubMed  Google Scholar 

  35. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing effect of cancer cells by herpes simplex virus thymidine kinase gene is mediated by conneins. Proc Natl Acad Sci USA. 1996;93:1831–5.

    Article  CAS  PubMed  Google Scholar 

  36. Matono S, Tanaka T, Sueyoshi S, Yamana H, Fujita H, Shirouzu K. Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer. Int J Oncol. 2003;23:1309–15.

    CAS  PubMed  Google Scholar 

  37. Erbs P, Regulier E, Mehtali M, et al. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res. 2000;60:3813–22.

    CAS  PubMed  Google Scholar 

  38. Tomko R, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroups C adenoviruses and subgroup B coxackieviruses. Proc Natl Acad Sci USA. 1997;94:3352–6.

    Article  CAS  PubMed  Google Scholar 

  39. Miyagawa K, Sakakura C, Otsuji E, et al. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis. Anticancer Res. 2008;28:1169–79.

    CAS  PubMed  Google Scholar 

  40. Goldenberg DM, Sharkey RM, Primus FJ. Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections. J Natl Cancer Inst. 1976;57:11–22.

    CAS  PubMed  Google Scholar 

  41. Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Cancer. 2007;109:188–97.

    Article  CAS  PubMed  Google Scholar 

  42. Heideman DA, Snijders PJ, Gerritsen WR, et al. Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAMtargeted adenoviral vectors. Cancer Gene Ther. 2001;8:342–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Shoko Nakata for valuable technical advice, and Hiroko Taniguchi and Kenichi Iyama for assistance in performing histological examinations.

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto-City, Kumamoto, Japan

    Yu Imamura MD, Shinji Ishikawa MD, PhD, Nobutaka Sato MD, Ryuichi Karashima MD, Kotaro Hirashima MD, Yukiharu Hiyoshi MD, Youhei Nagai MD, Yoshikatsu Koga MD, Naoko Hayashi MD, PhD, Masayuki Watanabe MD, PhD & Hideo Baba MD, PhD, FACS

  2. Center for Animal Resources and Development (CARD), Institute of Molecular Embryology and Genetics, and Global COE “Cell Fate Regulation Research and Education Unit”, Kumamoto University, Kumamoto-City, Kumamoto, Japan

    Gen Yamada PhD

Authors
  1. Yu Imamura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shinji Ishikawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobutaka Sato MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryuichi Karashima MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kotaro Hirashima MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yukiharu Hiyoshi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Youhei Nagai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshikatsu Koga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Naoko Hayashi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masayuki Watanabe MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Gen Yamada PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hideo Baba MD, PhD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideo Baba MD, PhD, FACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Imamura, Y., Ishikawa, S., Sato, N. et al. Adenoviral Oncolytic Suicide Gene Therapy for a Peritoneal Dissemination Model of Gastric Cancer in Mice. Ann Surg Oncol 17, 643–652 (2010). https://doi.org/10.1245/s10434-009-0852-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0852-3

Keywords

Search

Navigation